While our research demonstrates that senescence plays a significant role in driving these transcriptional changes, additional factors, including PTHrP produced by breast cancer cells, are likely to play a contributory role in enhancing the osteoclastogenic potential of osteocytes, irrespective of cellular senescence (42). Here, PTHLH is linked to breast cancer.